[Antiviral agents for influenza].
Mitamura
Keiko
K
Department of Pediatrics, Kawasaki Municipal Hospital.
D000081:Acetamides; D000367:Age Factors; D000547:Amantadine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D024882:Drug Resistance, Viral; D006146:Guanidines; D006801:Humans; D009980:Influenza A virus / Q000201:enzymology; D007251:Influenza, Human / Q000188:drug therapy* / Q000517:prevention & control; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D053139:Oseltamivir; D011714:Pyrans; D012299:Rimantadine; D012794:Sialic Acids / Q000008:administration & dosage / Q000494:pharmacology; D014763:Viral Matrix Proteins / Q000037:antagonists & inhibitors; D053243:Zanamivir
D000081:Acetamides; D000998:Antiviral Agents; D006146:Guanidines; C031540:M-protein, influenza virus; D011714:Pyrans; D012794:Sialic Acids; D014763:Viral Matrix Proteins; D012299:Rimantadine; D053139:Oseltamivir; D000547:Amantadine; D009439:Neuraminidase; D053243:Zanamivir